Bergamot Essential Oil Contraindications
Bergamot essential oil contains furocoumarins (psoralens) that are phototoxic and can cause photosensitivity reactions after topical exposure followed by ultraviolet (UV) light exposure. [1]
Bergamot essential oil is contraindicated for use on sun-exposed skin with anticipated UV exposure because phototoxic dermatitis and hyperpigmentation can occur. [1]
Bergamot essential oil should be avoided as an ingestible product due to limited safety data and because essential-oil products are not regulated to the same standard as medications. [2]
Photosensitivity and Phototoxicity
Bergamot essential oil contains furocoumarins such as bergapten and is associated with phototoxic and melanogenic properties. [1]
Topical exposure followed by UVA/UV exposure can cause an acute phototoxic reaction and subsequent hyperpigmentation consistent with classic “berloque dermatitis” patterns. [3]
Sun/UV Exposure Contraindication
Topical bergamot oil use is contraindicated immediately before or during planned sun exposure due to the risk of photosensitivity/phototoxicity after UV exposure. [4]
Non-FCF (furocoumarin-containing) bergamot preparations carry photosensitization risk because they can contain psoralens. [4]
Drug-Interaction Contraindication (Furocoumarin-Mediated CYP3A4 Inhibition)
Furocoumarin constituents in bergamot/related citrus oils can inhibit CYP3A4 and can contribute to clinically relevant drug interactions. [5]
Furocoumarins can inhibit CYP3A4 through mechanism-based inhibition, supported by human CYP3A4 inhibition studies using furanocoumarin monomers including bergamottin. [6]
Pregnancy and Lactation Caution/Contraindication
Safety data for essential oils used during pregnancy are limited, and topical application can cause allergic reactions, irritation, or sun sensitivity. [2]
Because of the phototoxicity risk from furocoumarins, bergamot essential oil use during pregnancy is contraindicated when UV exposure is possible. [1]
Practical Avoidance Criteria
Use is contraindicated for topical application when UV exposure is anticipated, including during outdoor activities or tanning exposure. [1]
Use is contraindicated on broken skin because irritation risk exists for essential-oil topical products. [2]
Use is contraindicated via ingestion because essential oils are not regulated for oral medical use and pregnancy-related guidance warns against ingestion. [2]
Key Safety Evidence Supporting These Contraindications
Furocoumarins in citrus-derived essential oils are described as phototoxic and photo-reactive compounds with documented photosensitivity consequences after UV exposure. [1]
Clinical-pattern documentation links bergamot-containing fragrance products to phototoxic dermatitis with UVA activation of psoralen components. [3]
Human enzyme studies show that furocoumarins related to bergamot can inhibit CYP3A4, supporting interaction risk for systems metabolized by CYP3A4. [6]
Furocoumarin drug-interaction reviews describe mechanism-based CYP3A4 inhibition as a recurring pathway for interactions involving grapefruit-related compounds and related citrus furanocoumarins. [5]
Enduring photosensitivity mechanisms are supported by reviews describing bergamot essential oil components that can induce phototoxic effects. [4]